COVID-19 IMPORTANT UPDATE
Due to the situation with the COVID-19 and the imposed travel restrictions and social distancing rules, and as we want to keep the face to face meeting form, the organizing committee has decided that the symposium will be rescheduled to 2021. The new meeting time and place will be announced soon.
This third international symposium for researchers and clinicians on Wiskott Aldrich Syndrome is being held in London UK and offers access to the latest research and analysis related to this rare disease.
Meeting participants will gain valuable insights into innovative perspectives in both basic and clinical research. The scientific programme will draw together experts from around the world to discuss breakthroughs in basic research, advances in clinical practice, novel therapeutic approaches and new insights into stem-cell and cellular therapies. An ideal forum to share knowledge, connect with professional colleagues and grow your professional network.
WAS 2020 is being held on the 19th October, 2020. We have timed the symposium to allow researchers who are travelling to also potentially visit the ESID2020 conference in Birmingham, UK between 14th October to 17th October, 2020.
- Expanding WAS/XLT and WASp research.
- Bridging the gap between basic and clinical research to speed up applications
- Foster collaboration among researchers.
- Attract young researchers to focus on WAS/XLT and WASp
- Abstract Submission Opens: January 15, 2020
- abstract Submission Deadline: Monday, June 1, 2020
Prof. Adrian Thrasher - Institute of child health, London.
Prof. Bobby Gaspar - Institute of child health, London.
Dr. Sumathi Iyengar - The Wiskott Aldrich Foundation.
Mr. Amir Kedar - The Wiskott Aldrich Syndrome association (R.A.).
The WAS2020 Symposium was made possible, in part, by a grant provided by the Jeffrey Modell Foundation WIN Program.
© 2019 by WAS2020.ORG